Back to All Bulletins
D;

docTLDR

India's 2-minute medical brief

October 24, 2025

15
Articles
3m 45s
Read Time

Today's Healthcare Brief

🏥General Healthcare News•Not specified

AI Revolutionizes Indian Healthcare: Faster Diagnoses, Less Burnout, But Human Touch Still Vital

AI-powered tools are transforming Indian medical facilities, automating note-taking, improving diagnostic accuracy, and supporting rural outreach. Major hospitals and startups are deploying AI for stroke, diabetic retinopathy, and remote monitoring. Experts urge balancing tech with empathy, as AI can't replace nuanced doctor-patient interactions.
#healthcare#india#general-healthcare-news
📋Doctor Affairs & Legal•Not specified

Supreme Court issues notice to Fortis in child brain injury case

The Supreme Court has issued a notice to Fortis Hospital Shalimar Bagh in response to a plea seeking Rs 1,350 crore compensation for alleged medical negligence that resulted in a child's permanent brain injury during birth. The case highlights serious concerns over the qualifications of the treating doctors, with the Delhi Medical Council having recently barred them from claiming specialist status. The matter is scheduled for further hearing in December 2025.
#healthcare#india#doctor-affairs-and-legal
Medical DialoguesRead Full →
🏥General Healthcare News•Not specified

NEET PG 2025 Counselling Delayed Again: Legal and Administrative Hurdles Disrupt Admissions

NEET PG 2025 counselling began 59 days after results, delayed by Supreme Court cases on exam transparency and pending seat matrix finalization by the NMC. The persistent delays create uncertainty for postgraduate medical admissions, impacting workforce planning and training schedules for hospitals.
#healthcare#india#general-healthcare-news
indianexpress.comRead Full →
🏥General Healthcare News•Not specified

Cipla to Launch Eli Lilly’s Weight-Loss Drug in India, Expanding Obesity Treatment Options

Cipla has signed an agreement with Eli Lilly to distribute its blockbuster weight-loss drug in India under a different brand name. This move is expected to improve access to advanced anti-obesity therapy for Indian patients, offering clinicians a new tool in managing the rising burden of obesity and related metabolic disorders.
#healthcare#india#general-healthcare-news
indianexpress.comRead Full →
📋Doctor Affairs & Legal•Leigh Page

Canada eases pathway for international physicians in 2025

Canada is streamlining its licensing process for international physicians in 2025, aiming to address critical doctor shortages. New policies will simplify credential recognition, reduce bureaucratic delays, and offer more support for foreign-trained doctors. These changes are expected to benefit Indian physicians seeking opportunities abroad, making Canada a more accessible destination for medical professionals.
#healthcare#india#doctor-affairs-and-legal
📋Medical Research•Not specified

Kiwifruit: Potent Vitamin C Source for Gut, Immunity & Heart Health

Kiwifruit is exceptionally rich in vitamin C, surpassing many common fruits, and offers significant health benefits including enhanced immune function, improved digestive health via fiber and actinidin enzyme, and cardiovascular support through antioxidant and potassium content. Clinical studies show regular consumption (2–3 kiwifruit/day) improves bowel regularity, reduces blood pressure, and may boost iron absorption, making it a valuable dietary addition for managing constipation, hyperten...
#healthcare#india#medical-research
News MedicalRead Full →
📋Medical Journals•Not specified

AI Oncology Platform HONeYBEE Promises Smarter Survival Predictions for Indian Cancer Care

The HONeYBEE platform leverages multimodal AI to enhance survival prediction in cancer patients, outperforming traditional clinical features. Indian oncologists can anticipate more personalized prognostics and treatment planning, potentially improving outcomes in resource-limited settings.
#healthcare#india#medical-journals
📋Medical Journals•Not specified

Breakthrough: Capsaicin’s Cardiac Effects May Guide Dementia Care in India

A new animal study highlights that capsaicin-induced cardiopulmonary reflexes and heart rate variability are reduced in dementia models. This could inform Indian clinicians about potential cardiac monitoring strategies in dementia patients, especially where capsaicin-rich diets are common.
#healthcare#india#medical-journals
📋Medical Journals•Department of Pharmacology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education

New Indian Study Flags Epinephrine’s Cardiovascular Risks: Rethink Emergency Protocols

A fresh investigation from Kasturba Medical College, Mangalore, reveals significant cardiovascular adverse effects linked to epinephrine use in Indian patients. The study urges clinicians to closely monitor for arrhythmias and hypertension during emergency interventions, suggesting a need to update local protocols for safer administration.
#healthcare#india#medical-journals
🧪Medical Technology & Devices•Health Ministry Officials

Alert: 52 Drug Samples Fail Quality Tests—Doctors Urged to Check CDSCO Portal for Monthly Updates

Central Drugs Laboratories flagged 52 drug samples as 'not of standard quality' in September 2025, with state labs identifying 60 more. Doctors should consult the CDSCO portal for monthly NSQ lists to avoid prescribing substandard or spurious medicines. Vigilance is crucial for patient safety and regulatory compliance.
#healthcare#india#medical-technology-and-devices
The Economic TimesRead Full →
📋Pharmaceutical News & Updates•Not specified

Telangana DCA Cracks Down on Illegal Cardiac Stimulant Sales: Mephentermine Sulphate in Focus

The Telangana Drugs Control Administration has launched a crackdown on the illegal sale of mephentermine sulphate injection, a potent cardiac stimulant. Doctors should be alert to possible misuse or unregulated supply of this drug, especially in emergency and critical care settings.
#healthcare#india#pharmaceutical-news-and-updates
📋Technology & Innovation•Not specified

Hyderabad hospital launches DNA test to guide personalised drug therapy

AIG Hospitals, Hyderabad, has launched a new genetic test that analyses patients’ DNA to predict individual responses to medications. This pharmacogenomics test aims to help doctors select the most effective and safe drugs for each patient, reducing trial-and-error prescribing and adverse reactions. The initiative marks a significant step towards precision medicine in India, making personalised therapy more accessible.
#healthcare#india#technology-and-innovation
📋Doctor Affairs & Legal•Not specified

Doctors protest after Uluberia hospital assault on woman colleague

Doctors and nurses at Sarat Chandra Chattopadhyay Medical College, Uluberia, are demanding swift justice after a woman junior doctor was assaulted by a traffic home guard and his relatives in the hospital’s antenatal ward. The incident, involving physical violence and threats, has led to arrests and prompted a 'pen down' protest, with demands for improved security, restricted access for patient relatives, and enhanced CCTV coverage. Authorities have promised infrastructure upgrades and a dedi...
#healthcare#india#doctor-affairs-and-legal
Telegraph IndiaRead Full →
📋Medical Research•Not specified

COVID mRNA vaccines may double survival in advanced cancer patients

A major study from MD Anderson Cancer Center found that advanced lung and melanoma patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived significantly longer than unvaccinated peers. Median survival for lung cancer nearly doubled (20.6 to 37.3 months), and melanoma patients also saw substantial gains. The effect is attributed to the vaccine's ability to broadly activate the immune system, enhancing the efficacy of immune checkpoint inhibitors. These fin...
#healthcare#india#medical-research
News MedicalRead Full →
📋Medical Research•Not specified

Latest Evidence Links Diabetes to Increased Dementia Risk and Subtypes

Emerging research confirms both type 1 and type 2 diabetes significantly elevate dementia risk, including Alzheimer’s and vascular dementia. Type 1 diabetes doubles all-cause dementia risk, while type 2 diabetes increases risk by 1.6-fold. Mechanisms include insulin resistance, chronic hyperglycemia, and vascular injury. Early glycemic control and tailored interventions may help delay cognitive decline, underscoring the need for proactive management in diabetic patients.
#healthcare#india#medical-research

Stay Updated with docTLDR

Get tomorrow's medical brief delivered to your inbox at 7 AM IST. Join 1000+ Indian doctors who trust us for their daily healthcare updates.

âś… No ads âś… No spam âś… Unsubscribe anytime